ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000271387.1	ABT-263 (navitoclax)	Skin cutaneous melanoma	0.033788656	Resistant
ENSG00000271387.1	ABT-263 (navitoclax)	Breast invasive carcinoma	0.01138758	Sensitive